CA2332121A1 - Procedes pour l'inhibition d'activite tef-3 - Google Patents
Procedes pour l'inhibition d'activite tef-3 Download PDFInfo
- Publication number
- CA2332121A1 CA2332121A1 CA002332121A CA2332121A CA2332121A1 CA 2332121 A1 CA2332121 A1 CA 2332121A1 CA 002332121 A CA002332121 A CA 002332121A CA 2332121 A CA2332121 A CA 2332121A CA 2332121 A1 CA2332121 A1 CA 2332121A1
- Authority
- CA
- Canada
- Prior art keywords
- tef
- cdna
- cells
- binding
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
L'invention concerne des procédés <i>in vivo</i> ou <i>in vitro</i> de sélection d'inhibiteurs d'activité TEF-3. L'invention concerne en outre des procédés permettant d'identifier des facteurs d'interaction de TEF-3. Enfin, l'invention concerne des procédés pour le traitement d'affections à médiation métalloprotéase matricielle, y compris celles du système musculo-squelettique, et du muscle cardiaque, ainsi que de maladies squelettiques liées à la croissance.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9131898P | 1998-06-30 | 1998-06-30 | |
US60/091,318 | 1998-06-30 | ||
PCT/US1999/014829 WO2000000161A2 (fr) | 1998-06-30 | 1999-06-30 | Procedes pour l'inhibition d'activite tef-3 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2332121A1 true CA2332121A1 (fr) | 2000-01-06 |
Family
ID=22227169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002332121A Abandoned CA2332121A1 (fr) | 1998-06-30 | 1999-06-30 | Procedes pour l'inhibition d'activite tef-3 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1089794A2 (fr) |
JP (1) | JP2002519008A (fr) |
AU (1) | AU5086699A (fr) |
CA (1) | CA2332121A1 (fr) |
IL (1) | IL140058A0 (fr) |
NO (1) | NO20006198L (fr) |
WO (1) | WO2000000161A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003001906A1 (fr) * | 2001-06-27 | 2003-01-09 | Takeda Chemical Industries, Ltd. | Procede de construction d'un modele animal de maladie des articulations |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5824794A (en) * | 1994-12-23 | 1998-10-20 | Syntex (U.S.A.) Inc. | Human stromelysin-1 promoter |
US5569588A (en) * | 1995-08-09 | 1996-10-29 | The Regents Of The University Of California | Methods for drug screening |
EP0935753A4 (fr) * | 1996-10-31 | 1999-12-08 | Merck & Co Inc | Epreuve biologique et lignee cellulaire aux fins de l'identification de mimetiques d'hormone de croissance |
AU6015098A (en) * | 1997-02-24 | 1998-09-09 | Cornell Research Foundation Inc. | Method of screening agents as candidates for drugs or sources of drugs |
-
1999
- 1999-06-30 AU AU50866/99A patent/AU5086699A/en not_active Abandoned
- 1999-06-30 EP EP99935376A patent/EP1089794A2/fr not_active Withdrawn
- 1999-06-30 CA CA002332121A patent/CA2332121A1/fr not_active Abandoned
- 1999-06-30 JP JP2000556746A patent/JP2002519008A/ja not_active Withdrawn
- 1999-06-30 WO PCT/US1999/014829 patent/WO2000000161A2/fr not_active Application Discontinuation
- 1999-06-30 IL IL14005899A patent/IL140058A0/xx unknown
-
2000
- 2000-12-06 NO NO20006198A patent/NO20006198L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU5086699A (en) | 2000-01-17 |
WO2000000161A2 (fr) | 2000-01-06 |
NO20006198L (no) | 2001-02-28 |
WO2000000161A3 (fr) | 2001-01-04 |
NO20006198D0 (no) | 2000-12-06 |
JP2002519008A (ja) | 2002-07-02 |
EP1089794A2 (fr) | 2001-04-11 |
IL140058A0 (en) | 2002-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8187596B1 (en) | Method of treating asthma or allergy by administering an IL-33 receptor antibody | |
JP2002504818A (ja) | リガンドファミリーのntn−2メンバー | |
CN106459993A (zh) | Fgfr融合体 | |
WO2020081556A2 (fr) | Complexe swi/snf non canonique et ses utilisations | |
JP4975444B2 (ja) | 創薬標的タンパク質及び標的遺伝子、並びにスクリーニング方法 | |
JPWO2007026969A1 (ja) | 創薬標的タンパク質及び標的遺伝子、並びにスクリーニング方法 | |
US20070117138A1 (en) | Splice variant cannabinoid receptor (cb1b) | |
JP2002523078A (ja) | 新規なirap−bpポリペプチド及び核酸分子並びにこれらの利用法 | |
AU2003244713A1 (en) | Histone deacetylase: novel molecular target of neurotoxicity | |
CA2332121A1 (fr) | Procedes pour l'inhibition d'activite tef-3 | |
JP2002514078A (ja) | Fthma−070関連蛋白質ファミリーおよびt85関連蛋白質ファミリーの新規分子ならびにそれらの使用 | |
JP2002534114A (ja) | 新規lrsgタンパク質および核酸分子ならびにそのための用途 | |
JPH09506243A (ja) | レセプター認識因子、蛋白配列およびその使用方法 | |
JP2002508934A (ja) | Tnfレセプターに対して相同性を有する、新規な核酸およびポリペプチド | |
US20160187340A1 (en) | Compositions, Kits, and Methods for the Modulation of Immune Responses Using Galectin-1 | |
WO1997031931A1 (fr) | Nouvelle disintegrine-metalloprotease et procedes d'utilisation | |
US20020102614A1 (en) | Use of ZPR1 as a molecular probe for spinal muscular atrophy | |
JPH10337192A (ja) | ヒトプロテインキナーゼhoacf72 | |
JP2002509707A (ja) | 肺腫瘍細胞を同定するための組成物および方法 | |
EP1613769A1 (fr) | Gene induit par l'insuline utilise comme cible therapeutique dans le diabete | |
JP2003530883A (ja) | Nf−at相互作用タンパク質nip45変異体の調節 | |
US20040033226A1 (en) | Osteopontin, oligodendrocytes and myelination | |
JP2005535313A (ja) | オステオポンチン、オリゴデンドロサイトおよび髄鞘形成 | |
Blanco | DNA polymerase mu and uses thereof | |
KR20050016628A (ko) | 오스테오폰틴, 희돌기교세포 및 수초화 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |